Table 2.
Modified ITTa analysis (n=412) | |||||
---|---|---|---|---|---|
Variable | Standard Error | p (sig.) | OR | 95% Confidence Interval | |
Lower | Upper | ||||
Placebo (reference) | - | - | - | - | - |
HTc+Calcitriol | .519 | .979 | 1.014 | .367 | 2.805 |
HT | .465 | .277 | 1.657 | .666 | 4.120 |
Calcitriol | .505 | .772 | 1.158 | .430 | 3.117 |
Baseline GDSb score | .398 | .000 | 10.699 | 4.902 | 23.352 |
Compliers analysis (n=337) | |||||
Placebo (reference) | - | - | - | - | - |
HTc+Calcitriol | .666 | .776 | 1.199 | .343 | 4.183 |
HT | .588 | .140 | 2.224 | .769 | 6.428 |
Calcitriol | .605 | .305 | 1.774 | .594 | 5.303 |
Baseline GDS score | .513 | .000 | 12.368 | 5.061 | 30.225 |
Intent to treat
Geriatric Depression Screening score
Hormone therapy with conjugated equine estrogens 0.625 mg/daily in hysterectomized women or combined with medroxyprogesterone acetate 2.5 mg/daily in women with intact uterus